Uncategorized

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – February 10, 2024

Mirum Pharmaceuticals, Inc. announced that on February 9, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 33,200 shares of common stock and 16,610 restricted stock units to seven new employees under Mirum’s 2020 Inducement Plan.

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – February 10, 2024 Read More »

Scroll to Top